R. Herranz

479 total citations
20 papers, 279 citations indexed

About

R. Herranz is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, R. Herranz has authored 20 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Surgery. Recurrent topics in R. Herranz's work include Colorectal Cancer Surgical Treatments (7 papers), Colorectal and Anal Carcinomas (7 papers) and Pancreatic and Hepatic Oncology Research (4 papers). R. Herranz is often cited by papers focused on Colorectal Cancer Surgical Treatments (7 papers), Colorectal and Anal Carcinomas (7 papers) and Pancreatic and Hepatic Oncology Research (4 papers). R. Herranz collaborates with scholars based in Spain and Chile. R. Herranz's co-authors include Felipe A. Calvo, M. Gómez-Espí, Miguel A. Lozano, R. Matute, Juan A. Díaz-González, Claudio V. Sole, Pilar Marcos, J.L. García-Sabrido, Emilio Álvarez and Pilar Alfonso and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, Radiotherapy and Oncology and European Journal of Nuclear Medicine and Molecular Imaging.

In The Last Decade

R. Herranz

20 papers receiving 274 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Herranz Spain 11 184 105 89 60 47 20 279
W. Chris Sheils United States 5 79 0.4× 102 1.0× 119 1.3× 67 1.1× 47 1.0× 6 298
Eren Celik Germany 11 128 0.7× 52 0.5× 112 1.3× 36 0.6× 68 1.4× 25 270
I. Troussier France 9 110 0.6× 138 1.3× 127 1.4× 61 1.0× 55 1.2× 28 316
Arthur Cheung Canada 8 91 0.5× 25 0.2× 93 1.0× 50 0.8× 36 0.8× 13 236
A. Paix France 7 115 0.6× 35 0.3× 83 0.9× 48 0.8× 61 1.3× 12 257
Sebastião Francisco Miranda Corrêa Brazil 5 45 0.2× 94 0.9× 103 1.2× 70 1.2× 46 1.0× 5 295
A. M. Le Ridant France 7 89 0.5× 188 1.8× 128 1.4× 19 0.3× 45 1.0× 10 356
Rituraj Upadhyay United States 9 98 0.5× 30 0.3× 116 1.3× 30 0.5× 50 1.1× 38 253
Priyanka Patel United Kingdom 9 87 0.5× 45 0.4× 142 1.6× 42 0.7× 71 1.5× 23 251
Esther de Luis Spain 8 38 0.2× 88 0.8× 127 1.4× 21 0.3× 75 1.6× 15 338

Countries citing papers authored by R. Herranz

Since Specialization
Citations

This map shows the geographic impact of R. Herranz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Herranz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Herranz more than expected).

Fields of papers citing papers by R. Herranz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Herranz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Herranz. The network helps show where R. Herranz may publish in the future.

Co-authorship network of co-authors of R. Herranz

This figure shows the co-authorship network connecting the top 25 collaborators of R. Herranz. A scholar is included among the top collaborators of R. Herranz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Herranz. R. Herranz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fernández, C., Mariana H.G. Monje, Víctor Gómez‐Mayordomo, et al.. (2022). Long-term directional deep brain stimulation: Monopolar review vs. local field potential guided programming. Brain stimulation. 15(3). 727–736. 21 indexed citations
2.
Sole, Claudio V., et al.. (2016). ecancermedicalscience. ecancermedicalscience. 7. 339–339. 8 indexed citations
3.
Sole, Claudio V., Felipe A. Calvo, Alejandro Berlín, et al.. (2014). Role of radiotherapy in the chemotherapy-containing multidisciplinary management of patients with resected pancreatic adenocarcinoma. Strahlentherapie und Onkologie. 191(1). 17–25. 1 indexed citations
4.
Sole, Claudio V., et al.. (2014). Multidisciplinary therapy for patients with locally oligo-recurrent pelvic malignancies. Journal of Cancer Research and Clinical Oncology. 140(7). 1239–1248. 3 indexed citations
5.
Calvo, Felipe A., Claudio V. Sole, A. Santos, et al.. (2013). Intraoperative radiation therapy opportunities for clinical practice normalization: Data recording and innovative development. Reports of Practical Oncology & Radiotherapy. 19(4). 246–252. 13 indexed citations
6.
Calvo, Felipe A., et al.. (2013). Intraoperative radiation therapy, opportunities for clinical practice normalization: MEDTING, a scientific platform. Reports of Practical Oncology & Radiotherapy. 19(4). 253–258. 1 indexed citations
7.
Calvo, Felipe A., Claudio V. Sole, Miguel A. Lozano, et al.. (2013). Chemoradiation for resected pancreatic adenocarcinoma with or without intraoperative radiation therapy boost: Long-term outcomes. Pancreatology. 13(6). 576–582. 16 indexed citations
8.
Calvo, Felipe A., Claudio V. Sole, M. Gómez-Espí, et al.. (2013). Prognostic Impact of External Beam Radiation Therapy in Patients Treated With and Without Extended Surgery and Intraoperative Electrons for Locally Recurrent Rectal Cancer: 16-Year Experience in a Single Institution. International Journal of Radiation Oncology*Biology*Physics. 86(5). 892–900. 14 indexed citations
9.
Calvo, Felipe A., Francisco Rivas, Claudio V. Sole, et al.. (2013). Post-chemoradiation anastomotic recurrence in locally advanced rectal cancer: no increased risk associated with distal margin. Clinical & Translational Oncology. 16(6). 573–580. 2 indexed citations
10.
Calvo, Felipe A., Claudio V. Sole, João Santos, et al.. (2013). Research opportunities in intraoperative radiation therapy: the next decade 2013–2023. Clinical & Translational Oncology. 15(9). 683–690. 18 indexed citations
11.
Sole, Claudio V., Felipe A. Calvo, Emilio Álvarez, et al.. (2013). Clinical significance of VEGFR-2 and 18F-FDG PET/CT SUVmax pretreatment score in predicting the long-term outcome of patients with locally advanced rectal cancer treated with neoadjuvant therapy. European Journal of Nuclear Medicine and Molecular Imaging. 40(11). 1635–1644. 13 indexed citations
12.
Díaz-González, Juan A., Felipe A. Calvo, Javier Cortés, et al.. (2005). Preoperative chemoradiation with oral tegafur within a multidisciplinary therapeutic approach in patients with T3-4 rectal cancer. International Journal of Radiation Oncology*Biology*Physics. 61(5). 1378–1384. 10 indexed citations
13.
Calvo, Felipe A., R. Matute, J.L. García-Sabrido, et al.. (2004). Neoadjuvant Chemoradiation With Tegafur in Cancer of the Pancreas. American Journal of Clinical Oncology. 27(4). 343–349. 35 indexed citations
14.
Calvo, Felipe A., M. Gómez-Espí, Juan A. Díaz-González, et al.. (2002). Intraoperative presacral electron boost following preoperative chemoradiation in T3–4Nx rectal cancer: initial local effects and clinical outcome analysis. Radiotherapy and Oncology. 62(2). 201–206. 47 indexed citations
15.
Calvo, Felipe A., M. Gómez-Espí, Juan A. Díaz-González, et al.. (2001). Pathologic downstaging of T3–4Nx rectal cancer after chemoradiation: 5-fluorouracil vs. Tegafur. International Journal of Radiation Oncology*Biology*Physics. 51(5). 1264–1270. 37 indexed citations
16.
Marcos, Pilar, et al.. (2000). Pathologic downstaging of T3-4 NX rectal cancer after chemo-radiation: 5-FU vs tegafur. International Journal of Radiation Oncology*Biology*Physics. 48(3). 122–122. 2 indexed citations
17.
Muxí, África, et al.. (1999). Radioimmunoguided surgery of colorectal carcinoma with an 111In-labelled anti-TAG72 monoclonal antibody. Nuclear Medicine Communications. 20(2). 123–130. 13 indexed citations
18.
Álvarez, Luisa, Pilar Peris, Núria Guañabens, et al.. (1999). Quantitative evaluation of bone scintigraphy in the assessment of Pagetʼs disease activity. Nuclear Medicine Communications. 20(6). 525–528. 20 indexed citations
19.
Herranz, R., et al.. (1995). [Wallenberg syndrome as a sign of rhombencephalitis-meningitis due to Listeria monocytogenes].. PubMed. 10(8). 342–5. 3 indexed citations
20.
Herranz, R., et al.. (1993). Radioimmunoscintigraphy of colorectal carcinoma with a 111In-labelled anti-TAG-72 monoclonal antibody. Nuclear Medicine Communications. 14(1). 775–787. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W. Chris Sheils Breakdown of academic impact, for papers by Eren Celik Breakdown of academic impact, for papers by I. Troussier Breakdown of academic impact, for papers by Arthur Cheung Breakdown of academic impact, for papers by A. Paix Breakdown of academic impact, for papers by Sebastião Francisco Miranda Corrêa Breakdown of academic impact, for papers by A. M. Le Ridant Breakdown of academic impact, for papers by Rituraj Upadhyay Breakdown of academic impact, for papers by Priyanka Patel Breakdown of academic impact, for papers by Esther de Luis
Rankless by CCL
2026